Olmesartan Medoxomil Tablets 20 mg
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.
MFDS item code 201100947 · Approved 2011.02.25
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of essential hypertension
Essential hypertension is treated to lower blood pressure to a normal range, reducing the strain on the cardiovascular system and the risk of complications. This medication helps control blood pressure in essential hypertension, preventing severe complications such as heart disease or stroke.
The recommended initial dose is 10 mg once daily, with or without food. If blood pressure is not adequately controlled, the dose may be increased to 20 mg once daily, up to a maximum of 40 mg. In patients where a reduction in effective intravascular blood volume is anticipated, treatment should start at a lower dose. For elderly patients (65 years or older), dose adjustment is not necessary. Patients with kidney impairment should be administered up to 20 mg once daily maximum.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this medication, pregnant or nursing women, patients undergoing kidney dialysis, patients with severe liver impairment, or those with biliary obstruction should not take this medication. When this medication is first administered to patients with reduced blood volume or salt, hypotension may occur, so their condition should be monitored closely, and appropriate measures taken if hypotension occurs. Patients with impaired kidney function or kidney transplant recipients should regularly check their kidney function and blood potassium levels through blood tests while taking this medication, and it is not recommended for patients with severe kidney impairment. Due to the risk of hyperkalemia, patients with risk factors for hyperkalemia should frequently check their blood potassium levels. This medication can cause dizziness, so caution is required when operating hazardous machinery or driving. This medication may cause various adverse reactions, with dizziness being the most common symptom. Rarely, angioedema or hepatic dysfunction, hyperkalemia, and acute renal failure may occur, so immediate consultation with a healthcare professional is necessary if abnormal symptoms arise. Chronic diarrhea and weight loss have been seldom reported in chronic malabsorption-like intestinal diseases, and this medication should be discontinued if such symptoms occur. When taken with potassium-sparing diuretics or potassium supplements, blood potassium levels may rise dangerously, so caution is advised in such cases. Taking this medication with other antihypertensive agents may enhance the hypotensive effect, so it should be taken according to the doctor's instructions. This medication should not be administered to pregnant women, as it may cause serious harm to the fetus, and nursing mothers should consider discontinuing either the medication or breastfeeding due to potential adverse reactions in infants. Safety has not been established in pediatric patients, so it is advisable not to use it in children. Elderly patients may have increased drug concentration in the body, so caution is required when taking it. In cases of overdose, symptoms such as hypotension and palpitations may occur, and appropriate treatment should be administered based on symptoms. Long-term use of this medication has not significantly reported carcinogenicity or genotoxicity risks, but it is important to regularly monitor individual reactions as the potential for adverse reactions may vary.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blistering, skin peeling, mucosal pain in the mouth/eyes, yellowing of the skin or eyes (jaundice), extreme lethargy, significantly reduced urine output, generalized swelling with concomitant hypertension, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, breathlessness
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent air or moisture from entering, and keep it at room temperature between 1 and 25 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer time.
White, round, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.